logo
#

Latest news with #Smallcap100

Best mid-cap stocks to buy today, 31 July, recommended by NeoTrader's Raja Venkatraman
Best mid-cap stocks to buy today, 31 July, recommended by NeoTrader's Raja Venkatraman

Mint

time31-07-2025

  • Business
  • Mint

Best mid-cap stocks to buy today, 31 July, recommended by NeoTrader's Raja Venkatraman

After months of turbulence, mid- and small-cap indices are showing signs of life this July. With mutual fund inflows accelerating and select pockets seeing renewed buying, the tides may be turning. But is it momentum or just a mirage? Dive into the shifting dynamics that are quietly reshaping India's broader market. Here are three mid-cap stocks to buy as recommended by NeoTrader's Raja Venkatraman for today: IPCALAB: Buy CMP and dips to ₹1,490 | Stop ₹1,475 | Target ₹1,650-1,740 TIMETECHNO: Buy CMP and dips to ₹450 | Stop ₹440 | Target ₹525-540 MUNJALSHOW: Buy at CMP and dips to ₹142 | Stop ₹138 | Target ₹163-171 Is sentiment under threat...? Over the 10 months to February 2025, the Nifty Midcap 100 and the Nifty Smallcap 100 plunged 14% and 16%, respectively, from their September 2024 peaks—deepening losses to roughly 21% and 25% below those highs—yet June's ₹3,754 crore inflows into mid-cap funds (and ₹4,024 crore into small-caps) helped July open on firmer ground. The Midcap 100 reclaimed about 1.5% early in July (Smallcap 100 added 1%), narrowing year-to-date deficits against the Nifty 50 even as both still lag large-caps. Against this backdrop, Q1 earnings from NSE 500 mid-cap constituents were mixed. Investors are rotating into mid-caps with stronger liquidity and clearer earnings visibility, while broader small-caps remain sensitive to valuation pressures and global risk sentiment—so July's tentative recovery hinges on selective stock picks and continued robust fund flows as these segments strive to close the valuation gap with their large-cap peers. Three mid-cap stocks to trade, recommended by NeoTrader's Raja Venkatraman: IPCA Laboratories Ltd (Cmp 1529.50) Why it's recommended: Ipca Laboratories Ltd (IPCALAB) is a pharmaceutical company engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs) and pharmaceutical formulations. Recently, the prices have dipped into the cloud support and formed a rounding pattern. The long body bullish candle seen on Friday augurs well for the prices. This has led to an improvement in the sentiment. With prices holding firm we can consider going long. Key metrics: P/E: 59.61 | 52-week high: ₹1,757.65 | Volume: 501.36K Technical analysis: Support at ₹1,420, resistance at ₹1,700. Risk factors: Macroeconomic and political risks, cyberattacks and weak same-store sales. Buy at: CMP and dips to ₹1,490. Target price: ₹1,650-1,740 in one month. Stop loss: ₹1,475. Time Technoplast Ltd (Cmp 472.15) Why it's recommended: Time Technoplast is the world's largest manufacturer of large-size plastic drums, with an impressive 50-60% market share in India and a significant share in 10 other countries. The stock has been consolidating at the TS & KS bands and forming long body candle patterns and inching higher. With momentum showing some upside once again we can look to go long. Key metrics: P/E: 61.49 | 52-week high: ₹513.35 | Volume: 1.98M Technical analysis: Support at ₹430, resistance at ₹550. Risk factors: Fluctuations in crude and polymer prices, intense competition and debt reduction. Buy at: CMP and dips to ₹450. Target price: ₹525-540 in one month. Stop loss: ₹440. Munjal Showa Ltd (Cmp 150.12) Why it's recommended: The counter has undergone some ranging action as moving steadily higher forming a higher high higher low since mid-May 2025. On a recovery it faced a value area resistance that kept halting the upmove forming higher high and higher lows holding the TS & KS Bands for the past few days around 140 has been overcome. With steady volumes building up within the bands one can look for an encouraging upmove in the coming days. Key metrics: P/E: 20.94 | 52-week high: ₹192.35 | Volume: 91.59K. Technical analysis: Support at ₹130, resistance at ₹170. Risk factors: MSL relies heavily on a single customer, the possibility of manufacturing defects and fluctuations in raw material prices. Buy: CMP and dips to ₹142 Target price: ₹163-171 in one month. Stop loss: ₹138. Overall, midcap and small-cap stocks still hold appeal for those chasing returns above traditional large-cap equities. Yet their propensity for swift price movements calls for a robust game plan, disciplined execution, and comprehensive due diligence. As themes in emerging markets shift—propelled by economic growth and technological breakthroughs—savvy investors who carefully weigh these growth prospects against their accompanying risks are well-positioned to reap meaningful gains over the long haul. Raja Venkatraman is co-founder, NeoTrader. His Sebi-registered research analyst registration no. is INH000016223. Investments in securities are subject to market risks. Read all the related documents carefully before investing. Registration granted by Sebi and certification from NISM in no way guarantees performance of the intermediary or provide any assurance of returns to investors. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.

Stocks to buy under ₹100: Experts recommend four shares to buy today — 28 July 2025
Stocks to buy under ₹100: Experts recommend four shares to buy today — 28 July 2025

Mint

time28-07-2025

  • Business
  • Mint

Stocks to buy under ₹100: Experts recommend four shares to buy today — 28 July 2025

Stocks to buy under ₹ 100: The Indian stock market extended its selling for the second straight session on Friday. The Nifty 50 index broke below the 50-DEMA support and finished nearly 400 points lower from the weekly high at 24,837. This marks Nifty's fourth consecutive week of losses, with a weekly decline of 0.53%. On Friday, Cipla, SBI Life, and Apollo Hospitals demonstrated strength in a broadly negative market, standing out as the Nifty's top performers. Conversely, it was a tough session for financial heavyweights, with Bajaj Finance, Shriram Finance, and IndusInd Bank ending as the major losers. Trading volumes on the NSE cash market were lower by 4% compared to yesterday. Baring, Nifty Pharma and Healthcare, and all other sectoral indices ended in red. Nifty Media, PSU Banks, Oil & Gas, and Metal fell sharply, registering the steepest declines and bearing the brunt of the selling pressure. The pain was even more acute in the broader market today, with the Nifty Midcap 100 and Smallcap 100 indices significantly underperforming the benchmark. The Nifty Midcap 100 Index plunged 1.61%, while the Nifty Smallcap 100 Index plummeted 2.10%. Market breadth remained weak for the seventh day, where declining shares surpassed advancers. The advance-decline ratio on the BSE stood at 0.40, the lowest since 19 June. On the outlook of the Indian stock market today, Siddhartha Khemka, Head of Research — Wealth Management, Motilal Oswal, said, "We expect the market to remain in consolidation mode amid continued uncertainty around the India-US trade deal, a mixed Q1FY26 earnings season so far, and intensifying FII outflows. Key results over the weekend include Kotak Mahindra Bank, Macrotech Developers, and CDSL, amongst others." Speaking on the outlook of the Nifty 50 today, Rajesh Bhosale, Equity Technical Analyst, Angel One, said, "The chart structure has deteriorated for the bulls. On the daily chart, the Nifty 50 had been trading within a "Rising Channel" pattern since May. However, this week's breakdown below the channel's lower boundary confirms a bearish reversal. Importantly, this breakdown is accompanied by a bearish gap, which qualifies as a "Breakaway Gap", adding further conviction to the bearish setup. Additionally, the index has broken below the 50-DEMA, a level that had previously provided strong support. This shift marks a significant change in short-term momentum for the bears. On the indicator front, the RSI Smoothened has slipped below 39, a level not seen since the April swing lows, reinforcing the weakening trend. These signals suggest the potential for deeper downside, possibly towards the 200-day SMA, which lies in the 24,200–24,000 zone. For the coming week, immediate support is placed near the 89-day EMA at 24,650, followed by the 24,500 level, which has acted as a strong base during the May–June consolidation phase. On the upside, the bearish gap and the 50-DEMA zone around 24,950–25,000 now act as immediate resistance, while the 25,250 level, the high of the last two weeks, remains a stiff barrier." Asked about the outlook of the Bank Nifty today, Shiju Kuthupalakkal, Senior Manager of Technical Research at Prabhudas Lilladher, said, "The Bank Nifty index continued with the slide with a weak candle indication on the daily chart, and once again is on the way to retest the important 50-DEMA zone near the 56,000 level, which is the crucial support. The index needs to sustain the 50-DEMA zone to keep the bias intact; otherwise, it can trigger a fresh downward slide in the coming sessions. At the same time, on the upside, Parekh added that the tough resistance barrier near the 57,300 zone needs to be breached decisively to expect fresh upward movement and strengthen the trend." Regarding stocks to buy today, market experts — Vaishali Parekh, Vice President — Technical Research at Prabhudas Lilladher; Mehul Kothari, Deputy Vice President — Technical Research at Anand Rathi; Sugandha Sachdeva, Founder of SS WealthStreet; and Anshul Jain, Head of Research at Lakshmishree Investment, recommended these four intraday stocks for today — Bodal Chemicals, IOB, Hazoor Multi Projects, and DCW. 1] Bodal Chemicals: Buy at ₹ 74.40, Target ₹ 78, Stop Loss ₹ 72. 2] IOB: Buy at ₹ 37 to ₹ 38, Target ₹ 42, Stop Loss ₹ 36. 3] Hazoor Multi Projects: Buy at ₹ 39.50, Targets ₹ 41.70, ₹ 42.50, Stop Loss ₹ 38.50. 4] DCW: Buy at ₹ 79, Target ₹ 85, Stop Loss ₹ 75.

Stocks to buy under  ₹100: Experts recommend four shares to buy today — 28 July 2025
Stocks to buy under  ₹100: Experts recommend four shares to buy today — 28 July 2025

Mint

time28-07-2025

  • Business
  • Mint

Stocks to buy under ₹100: Experts recommend four shares to buy today — 28 July 2025

Stocks to buy under ₹ 100: The Indian stock market extended its selling for the second straight session on Friday. The Nifty 50 index broke below the 50-DEMA support and finished nearly 400 points lower from the weekly high at 24,837. This marks Nifty's fourth consecutive week of losses, with a weekly decline of 0.53%. On Friday, Cipla, SBI Life, and Apollo Hospitals demonstrated strength in a broadly negative market, standing out as the Nifty's top performers. Conversely, it was a tough session for financial heavyweights, with Bajaj Finance, Shriram Finance, and IndusInd Bank ending as the major losers. Trading volumes on the NSE cash market were lower by 4% compared to yesterday. Baring, Nifty Pharma and Healthcare, and all other sectoral indices ended in red. Nifty Media, PSU Banks, Oil & Gas, and Metal fell sharply, registering the steepest declines and bearing the brunt of the selling pressure. The pain was even more acute in the broader market today, with the Nifty Midcap 100 and Smallcap 100 indices significantly underperforming the benchmark. The Nifty Midcap 100 Index plunged 1.61%, while the Nifty Smallcap 100 Index plummeted 2.10%. Market breadth remained weak for the seventh day, where declining shares surpassed advancers. The advance-decline ratio on the BSE stood at 0.40, the lowest since 19 June. On the outlook of the Indian stock market today, Siddhartha Khemka, Head of Research — Wealth Management, Motilal Oswal, said, "We expect the market to remain in consolidation mode amid continued uncertainty around the India-US trade deal, a mixed Q1FY26 earnings season so far, and intensifying FII outflows. Key results over the weekend include Kotak Mahindra Bank, Macrotech Developers, and CDSL, amongst others." Speaking on the outlook of the Nifty 50 today, Rajesh Bhosale, Equity Technical Analyst, Angel One, said, "The chart structure has deteriorated for the bulls. On the daily chart, the Nifty 50 had been trading within a "Rising Channel" pattern since May. However, this week's breakdown below the channel's lower boundary confirms a bearish reversal. Importantly, this breakdown is accompanied by a bearish gap, which qualifies as a "Breakaway Gap", adding further conviction to the bearish setup. Additionally, the index has broken below the 50-DEMA, a level that had previously provided strong support. This shift marks a significant change in short-term momentum for the bears. On the indicator front, the RSI Smoothened has slipped below 39, a level not seen since the April swing lows, reinforcing the weakening trend. These signals suggest the potential for deeper downside, possibly towards the 200-day SMA, which lies in the 24,200–24,000 zone. For the coming week, immediate support is placed near the 89-day EMA at 24,650, followed by the 24,500 level, which has acted as a strong base during the May–June consolidation phase. On the upside, the bearish gap and the 50-DEMA zone around 24,950–25,000 now act as immediate resistance, while the 25,250 level, the high of the last two weeks, remains a stiff barrier." Asked about the outlook of the Bank Nifty today, Shiju Kuthupalakkal, Senior Manager of Technical Research at Prabhudas Lilladher, said, "The Bank Nifty index continued with the slide with a weak candle indication on the daily chart, and once again is on the way to retest the important 50-DEMA zone near the 56,000 level, which is the crucial support. The index needs to sustain the 50-DEMA zone to keep the bias intact; otherwise, it can trigger a fresh downward slide in the coming sessions. At the same time, on the upside, Parekh added that the tough resistance barrier near the 57,300 zone needs to be breached decisively to expect fresh upward movement and strengthen the trend." Regarding stocks to buy today, market experts — Vaishali Parekh, Vice President — Technical Research at Prabhudas Lilladher; Mehul Kothari, Deputy Vice President — Technical Research at Anand Rathi; Sugandha Sachdeva, Founder of SS WealthStreet; and Anshul Jain, Head of Research at Lakshmishree Investment, recommended these four intraday stocks for today — Bodal Chemicals, IOB, Hazoor Multi Projects, and DCW. 1] Bodal Chemicals: Buy at ₹ 74.40, Target ₹ 78, Stop Loss ₹ 72. 2] IOB: Buy at ₹ 37 to ₹ 38, Target ₹ 42, Stop Loss ₹ 36. 3] Hazoor Multi Projects: Buy at ₹ 39.50, Targets ₹ 41.70, ₹ 42.50, Stop Loss ₹ 38.50. 4] DCW: Buy at ₹ 79, Target ₹ 85, Stop Loss ₹ 75. Disclaimer: The views and recommendations above are those of individual analysts or brokerage companies, not Mint. We advise investors to check with certified experts before making any investment decisions.

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — 28 July 2025
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — 28 July 2025

Mint

time26-07-2025

  • Business
  • Mint

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — 28 July 2025

Buy or sell stocks: The Indian stock market extended its selling for the second straight session on Friday. The Nifty 50 index broke below the 50-DEMA support and finished nearly 400 points lower from the weekly high at 24,837. This marks Nifty's fourth consecutive week of losses, with a weekly decline of 0.53%. Cipla, SBI Life, and Apollo Hospitals demonstrated strength in a broadly negative market, standing out as the Nifty's top performers on Friday. Conversely, it was a tough session for financial heavyweights, with Bajaj Finance, Shriram Finance, and IndusInd Bank ending as the major losers. Trading volumes on the NSE cash market were lower by 4% compared to yesterday. Baring, Nifty Pharma and Healthcare, and all other sectoral indices ended in red. Nifty Media, PSU Banks, Oil & Gas, and Metal fell sharply, registering the steepest declines and bearing the brunt of the selling pressure. The pain was even more acute in the broader market today, with the Nifty Midcap 100 and Smallcap 100 indices significantly underperforming the benchmark. The Nifty Midcap 100 Index plunged 1.61%, while the Nifty Smallcap 100 Index plummeted 2.10%. Market breadth remained weak for the seventh day, where declining shares surpassed advancers. The advance-decline ratio on the BSE stood at 0.40, the lowest since 19 June. Sumeet Bagadia, Executive Director at Choice Broking, believes the Indian stock market bias has weakened as the Nifty 50 index has decisively broken below the 50-DEMA support of 24,900. The Choice Broking expert said the key benchmark index may try to touch 24,700 to 24,650 levels in the subsequent few sessions. However, the crucial support for the 50-stock index is now placed at 24,500, whereas the index faces a hurdle of 25,050. He advised investors to maintain a stock-specific approach and look at those stocks that look strong on the technical chart. Regarding stocks to buy next week, Sumeet Bagadia recommended buying these three technically strong stocks: Sun Pharmaceutical Industries, HDFC Life Insurance Company, and Jindal Steel And Power. 1] Sun Pharma: Buy at ₹ 1699, Target ₹ 1850, Stop Loss ₹ 1620. Sun Pharma's share trades at ₹ 1,699 and maintains its overall uptrend, forming a consistent pattern of higher highs and lows. After recently reaching a record high, the stock has retraced toward its demand zone and is currently consolidating within a well-defined range. This consolidation phase appears constructive, supported by steady accumulation and consistent trading volumes, indicating growing buying interest at lower levels. The ongoing consolidation near key support zones sets the stage for a potential reversal. A sustained move above the ₹ 1,730 mark could act as a strong confirmation of this reversal and may open the door for a renewed upward trajectory. Such a breakout would end the current range-bound price action and reinforce the continuation of the broader uptrend. Given the encouraging chart setup, improving momentum, and volume-backed accumulation near demand zones, traders may consider buying Sun Pharma shares at ₹ 1,699, with a stop-loss at ₹ 1,620 to manage downside risk. A breakout and sustained move above ₹ 1,730 could pave the way for an upside toward ₹ 1,850 in the short to medium term, offering a favourable risk-reward opportunity for positional traders. 2] HDFC Life: Buy at ₹ 762.35, Target ₹ 825, Stop Loss ₹ 730. HDFC Life's share price is currently trading at ₹ 762.35 and remains in a broad uptrend, marked by a consistent formation of higher highs and higher lows on the higher timeframes over the past several months. After hitting a record high recently, the stock has undergone a healthy retracement, moving toward its demand zones, which has helped constructively reset the momentum. The stock shows signs of a potential reversal from these demand zones, supported by a stabilising price structure and renewed buying interest. A sustained move above the ₹ 775 mark could act as a breakout trigger and pave the way for the stock to resume its upward momentum, potentially revisiting its previous highs and extending beyond them in the near term. Considering the positive long-term structure, early signs of reversal, and momentum recovery, traders may look to buy HDFC Life shares at the current market price of ₹ 762.35, with a stop-loss placed at ₹ 730 to limit downside risk. A breakout and sustained move above ₹ 775 could unlock upside potential toward ₹ 825, offering an attractive setup for positional traders. 3] Jindal Steel And Power: Buy at ₹ 1000, Target ₹ 1090, Stop Loss ₹ 955. Jindal Steel's share price closed the day at ₹ 1,000.15, showcasing a strong technical breakout that signals the beginning of a potential uptrend. The stock recently completed the formation of a classic Inverted Head & Shoulders pattern, which is widely recognised as a bullish reversal structure, typically marking the end of a prior downtrend. The breakout above the neckline resistance at ₹ 980, backed by rising volumes, indicates a confirmed trend reversal with growing bullish momentum. The stock is now trading well above all its key exponential moving averages across short-term, medium-term, and long-term timeframes, reinforcing the strength of the ongoing upward trend. This alignment of moving averages adds credibility to the breakout and supports the case for continued bullish action. Momentum indicators are also in sync with the price structure. The Relative Strength Index (RSI) is in the bullish zone, reflecting strong buying interest, while the MACD is likely showing a positive crossover, supporting the ongoing trend. Additionally, the price is riding the upper Bollinger Band, a classic signal of trend strength and a potential sign of sustained momentum. Given the breakout structure, rising volumes, and momentum confirmation, traders may consider buying JINDALSTEL at the current market price of ₹ 1,000.15, with a stop-loss at ₹ 955 to manage downside risk. A sustained move above ₹ 1,000 could lead to further upside toward ₹ 1,090 in the short to medium term, offering a favourable setup for traders and investors. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Stock Market LIVE: Sensex gains 300 pts; Nifty above 25,000; HDFC Bank, ICICI Bank rise 2% each
Stock Market LIVE: Sensex gains 300 pts; Nifty above 25,000; HDFC Bank, ICICI Bank rise 2% each

Business Standard

time21-07-2025

  • Business
  • Business Standard

Stock Market LIVE: Sensex gains 300 pts; Nifty above 25,000; HDFC Bank, ICICI Bank rise 2% each

Sensex Today | Stock Market LIVE on Monday, July 21, 2025: In the broader markets Nifty Midcap 100 and Smallcap 100 were down 0.17 per cent and 0.28 per cent respectively 10:42 AM Stock Market LIVE Updates: Analysts up HDFC Bank target as credit growth, NIM set to improve Stock Market LIVE Updates: "HDFC Bank posted a steady quarter with a slight earnings beat due to tax reversals. We tweak our earnings estimates and project HDFC Bank to deliver an FY27 return on asset (RoA) of 1.9 per cent and a return on equity (RoE) of 14.9 per cent," said analysts at Motilal Oswal Financial Services. They reiterate their 'Buy' rating on HDFC Bank stock with a higher target price of ₹2,300. READ MORE 10:05 AM Stock Market LIVE Updates: Sensex, Nifty climb in a sudden spike 9:49 AM Stock Market LIVE Updates: AU SFB slips 7% after posting Q1 results; brokerages suggest 'Reduce' Stock Market LIVE Updates: AU Small Finance Bank shares slipped 7.3 per cent, logging an intraday low at ₹736.4 per share on BSE. The selling pressure came after the bank's Q1 numbers came in weak. At 9:34 AM, AU Small Finance Bank pared gains and the share price was trading 7.2 per cent lower at ₹737.35 per share on the BSE. In comparison, the BSE Sensex was down 0.2 per cent at 81,653.42. READ MORE 9:30 AM Stock Market LIVE Updates: These 8 stocks to go ex-date on July 22; do you own any? Stock Market LIVE Updates: Voltamp Transformers, Happy Forgings, Hind Rectifiers, Menon Pistons, SIL Investments, Siyaram Silk Mills, Strides Pharma Science, and Wires & Fabriks SA shares are expected to remain in spotlight today following their announcements of dividend rewards for shareholders. The BSE data suggests that they are slated to trade as they will trade ex-date tomorrow, Tuesday, July 22, 2025. Notably, the ex-date is the day a stock begins trading without the entitlement to corporate benefits such as dividends or bonus shares. Thus, the investors must hold the stock before the ex-date to be eligible for these benefits. The record date, however, is when the companies determine the list of shareholders who qualify for the corporate action. READ MORE 9:20 AM Stock Market LIVE Updates: A glance at broader market Stock Market LIVE Updates: In the broader markets, Nifty Midcap 100 index fell 0.3 per cent and Nifty Smallcap 100 fell 0.2 per cent during early trade. 9:19 AM Stock Market LIVE Updates: Sensex heatmap Stock Market LIVE Updates: Among the Sensex constituents, Reliance Industries, Axis Bank, Mahindra & Mahindra, Titan and Adani Ports were the top losers. 9:18 AM Stock Market LIVE Updates: Nifty50 opens below 25,000 Stock Markets LIVE Updates: The NSE Nifty50 opened at 25,958, down by marginally 9.65 points from its previous close.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store